(19)
(11) EP 1 248 607 A1

(12)

(43) Date of publication:
16.10.2002 Bulletin 2002/42

(21) Application number: 00988185.5

(22) Date of filing: 19.12.2000
(51) International Patent Classification (IPC)7: A61K 31/18, A61K 31/38, A61K 31/335, A61K 31/44, A61K 31/425, C07C 303/38, C07C 311/21, C07C 311/29, C07C 311/44, C07D 213/89, C07D 271/12, C07D 285/14, C07D 333/34, C07D 333/52, C07D 333/72
(86) International application number:
PCT/US0034/574
(87) International publication number:
WO 0104/5694 (28.06.2001 Gazette 2001/26)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.12.1999 US 172807 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • DHANAK, Dashyant
    West Chester, PA 19380 (US)
  • KNIGHT, Steven, D.
    West Chester, PA 19380 (US)

(74) Representative: Hockley, Siân Catherine et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) UROTENSIN-II RECEPTOR ANTAGONISTS